chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tingling sensation throughout whole body. Last from the date of the first shot through the date of the second shot. Got the second 4/7/2021. (Moderna Lot # 016BZ1A ) After the second shot, suffered severe headaches, pain was in the back of the head Was told to go to the hospital. Doctor did cat scan and MRI. Was told the he had TIA stroke.  Is place on "emergency watch." Told to go to doctor with any sign of headache because it could another stroke.
it went very bad with the 1st; This case was reported by a consumer via interactive digital media and described the occurrence of feeling bad in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced feeling bad. On an unknown date, the outcome of the feeling bad was recovered/resolved.   It was unknown if the reporter considered the feeling bad to be related to Shingles vaccine.     Linked case(s) involving the same patient:  US2022AMR164330   Additional Information: GSK Receipt Date: 07-NOV-2022 Reporter's comment: This case was reported by a patient via interactive digital media. The patient received 1st dose of Shingles vaccine and it went very bad with the first one, but he/she was fine at the time of reporting.  The patient's doctor told him/her that he/she could get a shingles vaccine. Additional supportive information: The follow-up would not possible, as no contact, details were available. Note: In narrative it was mentioned as after 2nd dose it almost didn't hurt but it was not clear whether patient hurt after 1st dose also, hence only feeling bad event was captured in the case.; Sender's Comments:  US-GSK-US2022AMR164330:same reporter and patient
Covid-19 Vaccine EUA; Severe pain and swelling of the injection sight and entire arm. Could barely walk the next morning as all extremities felt heavy and very weak. Required assistance from bathroom due to not being able to stand due to weakness and pain. Nausea present as well as dizziness. No fever but was very sweaty. Very fatigued. Took Motrin every 6 hours to help with pain. Second day after vaccination- left arm is still sore with swelling extending down into hand. Large bump at injection site as well as slight redness. Fatigue is still present. Still taking ibuprofen every 6 hours.
pt also received 2 additional Moderna  COVID vaccines - Moderna 11/9/21, lot #033F21A and on 5/3/22, lot #001M21A. pt was living in a nursing home, tested positive for COVID in nursing home; CT of the head showed left parietal intraparenchymal hemorrhage; DNR; High Point Hospice, saw pt for palliative care until he passed away in the nursing home.
Excursion from the freezer; Administered to 118 patients (08Nov2021- 14 given); This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Excursion from the freezer) and EXPIRED PRODUCT ADMINISTERED (Administered to 118 patients(08Nov2021- 14 given)) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939901) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Excursion from the freezer) and EXPIRED PRODUCT ADMINISTERED (Administered to 118 patients(08Nov2021- 14 given)). On 08-Nov-2021, PRODUCT TEMPERATURE EXCURSION ISSUE (Excursion from the freezer) and EXPIRED PRODUCT ADMINISTERED (Administered to 118 patients(08Nov2021- 14 given)) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was given.  No treatment medication was given. There was an excursion from their freezer on 01-Oct-2021.   Most recent FOLLOW-UP information incorporated above includes: On 15-Nov-2021: Additional information includes patient demographics, Dose details were added
This case was reported by a consumer via other manufacturer and described the occurrence of cough in a 82-year old male patient who received Influenza vaccine Quadrivalent. Co-suspect products included XTANDI (batch number 1543978PC, expiry date unknown) for prostate cancer. Concurrent medical conditions included prostate cancer. On an unknown date, the patient received Influenza vaccine Quadrivalent at an unknown dose and XTANDI (oral) 160 mg once daily. On 26th October 2016, less than a year after receiving Influenza vaccine Quadrivalent the patient experienced cough and cold. On an unknown date, the outcome of the cough and cold were unknown. It was unknown if the reporter considered the cough and cold to be related to Influenza vaccine Quadrivalent. Additional details were provided as follows: The age at vaccination was not reported. No medical history was provided. No concomitant medication information was provided. In 2016, the patient received a dose of Influenza vaccine Quadrivalent and XTANDI and developed cough and cold. No lab test information was provided. The medical reviewer assessed cough and cold possibly related to XTANDI based on the implied temporal association.
318 patients received dose from vials beyond 30-day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date). On 12-Oct-2021, EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant drugs were not reported. Treatment medications were not provided.  Date of refrigeration was reported on 10-08-2021.   This case was linked to MOD-2021-364559, MOD-2021-363032, MOD-2021-363226 (Patient Link).
Vaccine AM 11/30/06.  About 6 hrs later about 6-in area of redness at site. Since then generalized rash on all body surfaces, with target lesions, and with lip involvement.  Some areas with petechiae, some with ecchymoses. Pt hospitalized today (I'm ID consultant).  No trouble with previous yearly flu shots. No h/o egg allergy. 12/13/06-inpatient H&P and I& D Consultation report received and reviewed. Impression: E. multiforme-like rash following flu shot. Suspect that if this is related to vaccine the offending agent is in the vehicle rather than in the subvirion components since rash with flu infection itself is so very rare. Rash at injection site occurred 6-8 hours after vaccine. Now on trunk, lips are sore. Rash is mainly itchy not painful.  HX breast cancer August 2006.  01/12/07-DC summary received and reviewed for DOS 12/11-12/13/06 DC DX: Hypersensitivity Reaction Treated with Solu-Medrol. DC on Prednisone and Benadryl.  Have not been able to reach pt. for follow-up   Follow-up received APR 02 2007 - pt partially recovered. According to PCP much improved by 12/21 but referred to dermatologist for follow-up.
Had pneumonia 2 wks prior. Had Pneumovax on 2/18/08. That evening developed fever, arm was hard and swollen. This continued and came to ER on 2/20-temp reported 102.
Out of time range given to patient; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTRATION ERROR (Out of time range given to patient) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTRATION ERROR (Out of time range given to patient). At the time of the report, PRODUCT ADMINISTRATION ERROR (Out of time range given to patient) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19; This spontaneous report received from a patient via other manufacturer Pfizer concerned a 64 year old female . Initial information was processed along with the additional information received on 10-MAY-2022. The patient's height, and weight were not reported. The patient's concurrent conditions included: penicillin allergy, pollen allergy, dust allergy, and peanuts allergy, and other pre-existing medical conditions included: patient was not pregnant at the time of vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1802072, expiry: unknown) dose was not reported, 1 total administered on 11-MAR-2021 to left arm for prophylactic vaccination. Age at time of vaccination 63 years old. Concomitant medications included Citracal (calcium citrate), and Claritin (loratadine).  On 20-APR-2022, patient took ritonavir (Paxlovid) dose and was feeling better. On 28-APR-2022, Laboratory data included: COVID-19 virus test (NR: not provided) negative. On 29-APR-2022 at 12:00, the patient reported symptoms return (covid relapse) coded to suspected clinical vaccination failure and suspected covid-19. On 30-APR-2022, patient performed two different COVID-19 antigen test which resulted positive.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from suspected covid-19, and the outcome of suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint: 90000230236; Sender's Comments: V0: 20220517486-COVID-19 VACCINE AD26.COV2.S- suspected clinical vaccination failure. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS. Therefore, this event(s) is considered not related.
Body pins and needles started at 2 am/ tingling arms, hands, feet; fingers and toes numbness/ right heel numbness; tongue tingling; Heavy head; Slight headache; This is a spontaneous report from a contactable consumer (patient). A 55-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), intramuscular in right arm on 02Jun2021 13:00 (at the age of 55-years-old) as dose 1, single for COVID-19 immunization. Medical history included none. There were no concomitant medications. Prior to vaccination, the patient was not diagnosed with COVID-19, did not receive any vaccines within four weeks and was not pregnant. The patient was not having any known allergies. The patient experienced body pins and needles started at 2 am/ tingling arms, hands, feet, fingers and toes numbness/ right heel numbness, tongue tingling, heavy head and slight headache on 03Jun2021 02:00. The events Body pins and needles started at 2 am/ tingling arms, hands, feet, fingers and toes numbness/ right heel numbness and tongue tingling were considered as medically significant. Since the vaccination, patient has not been tested for COVID-19. No treatment was received for the event. The events were on and off intermittent, patient had right heel numbness every morning for couple hours. Outcome of events was resolving.
Myalgia, NauseaVomiting, blotches on back not raised, fatique Narrative:
4x6cm redness, slightly raised, warm to touch. Onset 24 hrs post immunization no fever no c/o pain. Worsened 24-48 hrs post immunization.
When I first reported reactions, I didn?t realize that the following could be a reaction.  The first night after having 2nd vaccination, I woke up about every hour with very strange dreams and the second night the same thing except didn?t wake up every hour. I typically don?t remember dreaming. I?m still having occasional dreams that I remember.
This spontaneous report was received from a healthcare worker referring to an unknown number of patients of unknown ages and genders. No concurrent or historical conditions were reported. Since 18-JAN-2016, the patients were vaccinated with improperly stored doses of VARIVAX (Merck) (Lot # L026410, expiration date 15-FEB-2017), doses, routes and anatomical locations were not provided. No concomitant medications were reported. No adverse effects were reported. No product quality complaint was involved. Temperature was reported as -11C, time frame 65.5 hours, outcome of excursion: supported. No previous temperature excursion was reported. Additional information has been requested.
Fatigue; Arm soreness; Caller is a pharmacist who is reporting administration of undiluted doses of the Pfizer-Biontech Covid19 vaccine to 4 total patients; Caller is a pharmacist who is reporting administration of undiluted doses of the Pfizer-Biontech Covid19 vaccine to 4 total patients; This is a spontaneous report from a Pfizer sponsored program. A contactable Pharmacist reporting same event under the same suspect product for 4 patients.   A female patient of 69-year-old age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was EW0185, Expiration date: 31Aug2021), via intramuscular at deltoid right on 02Jul2021 at 09:00 AM (age at vaccination: 69 years) as dose 2, single for COVID-19 immunization. Medical history was not reported. Concomitant medication was not reported. It was unknown that any additional vaccines administered on same date of the Pfizer suspect. It was unknown that patient had adverse event following prior vaccinations or patient's medical history (including any illness at time of vaccination). She received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on unknown date for COVID-19 immunization. Pharmacist reported higher than the recommended dose of the Pfizer Covid 19 vaccine. The product was not diluted before being given and was given to 4 patients. It was unknown that adverse event required emergency room or physician office visit. On 02Jul2021 at 12:00 patient experienced fatigue and arm soreness. Patient was given dose (Full undiluted vial) of vaccine for 2nd dose. Patient was affected soon upon realization and monitored via phone calls throughout weekend. Therapeutic measures were taken as a result of fatigue, pain in extremity which resolved with rest, fluids+ Tylenol/Advil. The clinical outcome of events product preparation issue and overdose was unknown, and events fatigue and arm soreness was recovered in 2021.  Follow-up attempts are completed. No further information is expected.  Follow-Up (26Jul2021): Follow-up attempts are completed. No further information is expected.  Follow-up (09Aug2021): This is a follow up spontaneous report from a contactable pharmacist. This pharmacist reported for a patient in response to HCP which included that: Updated information included: route of administration of suspect drug added, events fatigue and arm soreness were added, narrative was updated.  Follow-Up (18Aug2021): Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021830001 same reporter/drug/AE with different patient
I had difficulty concentrating and focusing on Wednesday evening, a little over a day after getting my first shot. The focusing/concentration issues went away by the next morning when I woke up, however I have been feeling very tired physically since then. I'm yawning all day and have very little energy or interest in doing things I need to be doing.  I'm not certain that this is vaccine related, and I'm not super concerned about it yet as I'm on Spring break from school, but I start virtual classes again on Monday and will be concerned if I'm still super tired. If it doesn't go away by next weekend, I will likely resubmit/add on to this report if that is an option.  It is not a serious concern yet so I haven't contacted medical professionals yet, but I thought it might be a good idea to at least report that this has been going on to VAERS
PREVENAR 13 administered approx. 10 or 11AM on 4/10/18. Notice non pruritic red papular rash on medial thighs about 10pm that night. Next morning rash over torso, ant/post, lightly scattered on arms, upper legs. No SOB, wheeze, swelling of lip to tongue, throat. Felt normal other than the rash. No Hx of rashes. Hx Amox allergy.
Referred to VHC by Dr. I'm experiencing side effects found on anthrax vaccine website to include: irregular bowel movement, joint pain, headaches, fluctuating heart rates, chest pain, no energy, fatigued easily, loss of short term memory, ringing in ears, elevated liver count. All are affecting ADL. MD's can't find a reason for shoulder pain and elevated liver count. "After explaining this to the doctor she is led to believe it is related to my anthrax vaccines I received in 1999."   CC:  concerned about persistent joint pain onset 6 months following 3rd AVA vaccination and progressive symptoms of depression, mood swings, memory deficits. This 33 year old male reported receiving three anthrax vaccinations: 17 Feb 1999 Lot FAV036, 17 Mar 1999 lot FAV033, and 31 Mar 1999 Lot FAV 033 prior to April 1999. He reported experiencing commonly reported adverse events of vaccine site pain and tenderness and stiffness for two weeks with the first vaccination, no adverse events remembered with AVA #2 or #3.    Approximately 6 months later (@Oct 1999) he began to experience left > right shoulder pain and stiffness describing a cracking-popping sensation especially when lifting weights. one year later c/o fatigue, depression; @ 2002 palpitations & c/o headaches. Med records remain pending.
patient was given the monovalent instead of the bivalent. no reaction or adverse event occurred. Patient was notified.
Lt upper arm redness, swelling, pain, decreased mobility & warm to touch. Fever 102 degrees F. Treatment: AUGMENTIN.
Information has been received from a licensed practical nurse concerning a 5 year old female who on an unspecified date was vaccinated with a dose of MMR II. Secondary suspect therapy included VARIVAX (Merck) (dose, route and lot number not reported) and RECOMBIVAX HB (manufacturer unknown) (dose, route and lot number not reported), DTAP (manufacturer unknown) (route and lot number not reported) and IPV (manufacturer unknown) route and lot number not reported). The licensed practical nurse reported that the patient came in with an extremely swollen thigh. The patient's mother stated that the patient was given all the vaccines in her thigh but the reporter could not find that information in the patient's record. It was reported that the treating physician gave the patient prednisone (manufacturer unknown) and she was able to leave. Additional information has been requested.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52-year-old male patient received BNT162b2 (BNT162B2), in Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 52 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, suspected covid-19. Clinical course: The patient was not taking any other medications/products within 2 weeks of starting COVID-19 treatment. The patient previously receives a COVID-19 Vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
PT had vaccine given 2 days ago 48 hours ago. Pt's Mother noted sore and swollen in the morning aroung 6am the swelling is growing. Not too pain full now. Exams: Left deltoid erythema and induration 10x10 cm (Adverse effects of other and unspecified viral and rickettsial vaccines influenza vacc)
Shingles outbreak. Began as shooting pains 3 days after vaccine. Rash/blisters 5 days after vaccine.
I got dizzy and experienced pain under my rib cage after 20 mins of getting the vaccine. Then I felt exhausted. I had severe upper arm pain at the injection shot. I was having symptoms of a UTI infection so I went to the doctor. They did a urine test and gave me antibiotics for it. I ended up getting thrush after 2 days of taking antibiotics. I had to go back to the doctor to get rid of the thrush. It made my chronic pain worse and in my lower back I felt a burning sensation. I had pain all over my body joints. The pain didn't go away until a month or 6 weeks later. The day after receiving the shot, the left side of my body was in pain. Then the next day I had pain on the right side of my body.
This spontaneous report as received from a Administrator, and refers to a 12 months old infant patient of unknown gender. No medical history, concurrent condition and concomitant medications were reported. On 16-MAY-2016, the patient was vaccinated with improperly stored dose of VARIVAX lot # L048468 (strength, dosing details, anatomical location were unknown). All the VARIVAX vaccines with lot # L048468, were moved to the backup freezer on 15-APR-2016 and moved back at the end of AUG-2016. This is one of the several reports reported by the same reporter. Additional information has been requested.
Information has been received from a physician concerning an 18 year old female who on 08-AUG-2007 was vaccinated with a first dose of Gardasil.  On 11-AUG-2007 the patient developed a headache.  The patient did not seek medical attention.  At the time of the report the patient was still experiencing the headaches.  Additional information has been requested.
Pt reports itchy tongue and lightheadedness. no h/o DM, no meds taken today. juice given
In October of 2022, I was having indigestion and back pain. Something was going on with my stomach, so I went to an urgent care clinic. They sent me to the emergency room, where they did a CAT scan and X-ray. They found a mass on my pancreas. They admitted me and diagnosed me with cancer. They did a surgery on 02/17/2023 to remove part of my pancreas. In November, I was doing chemotherapy until my surgery, and I have not started it again. During the end of December, I did contract COVID-19 since my immune system was not doing well. They prescribed me Paxlovid which I took for 5 or 6 days, and it knocked it out.
Antibody test negative; Information has been received from a health professional concerning a female employee who in February 1998 and April 1998 was vaccinated with doses of varicella virus vaccine live (Oka/Merck). A titer done in June 1998 was negative. She received a dose of varicella virus live (Oka/Mercek) again on 21-JUN-1999. A titer done on 13-JUL-1999 was positive. On -3-DEC-2001 the patient had another titer done that was negative. It was reported that the patient did not recover. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.